'Graft survival' diaporamas de présentation

Transplant Immunology

1.84k views • 87 slides

CHAPTER 13 RENAL TRANSPLANTATION

974 views • 74 slides

Organ Preservation with Histidine-Tryptophan-Ketoglutarate (HTK) Solution Clinical Results

Organ Preservation with Histidine-Tryptophan-Ketoglutarate (HTK) Solution Clinical Results. Bijan Eghtesad, M.D. John J. Fung, M.D. Ph.D. Department of General Surgery Cleveland Clinic. Orlando, 5/19/2007. Organ Preservation. P RESERVATIVE S OLUTIONS. Organ Preservation.

1.64k views • 65 slides

RENAL TRANSPLANTATION IN CHILDHOOD

RENAL TRANSPLANTATION IN CHILDHOOD. Lynne P. Yao, M.D. INOVA Fairfax Hospital for Children Fairfax, VA. Overview. Review basic transplantation immunology Review immunosuppressive agents used in children Review clinical renal transplantation outcomes in children

1.26k views • 56 slides

March 26 and April 1, 2009

Analysis and Review of Clinical and Scientific Findings of Preservation Solutions to Minimize Donor Organ Damage. March 26 and April 1, 2009. Histidine-Tryptophan-Ketoglutarate Solution Vs. University of Wisconsin Solution for Deceased Donor Liver Transplantation: Analysis of SRTR Database.

690 views • 55 slides

Transplant Immunology

Transplant Immunology. WHY TRANSPLANT TISSUES OR ORGANS? Replace dysfunctional/nonfunctional tissue or organs ------------------------------------------------------------------------------ - High technology medicine Specialized healthcare professionals Specialized facilities

713 views • 55 slides

Transplant Kidneys Sooner Discard Kidneys Less

Transplant Kidneys Sooner Discard Kidneys Less. Francis L. Delmonico, M.D., F.A.C.S. Professor of Surgery, Harvard Medical School Director, Renal Transplantation Massachusetts General Hospital Medical Director, New England Organ Bank. New England Organ Bank. For the year 2000:

594 views • 45 slides

674 views • 42 slides

Transplantation Science

Transplantation Science. Lars Wramner MD, Ph.D. Transplantation. Organs: Kidney, liver, heart, lung, pancreas Tissues: Cornea, skin, bone, heart valves Blood: Erythrocytes, trombocytes, plasma Bone marrow:. Transplantation. Autotransplantation Within one individual

685 views • 40 slides

Role of the procurement biopsy in the assessment of kidneys from marginal donors

Role of the procurement biopsy in the assessment of kidneys from marginal donors. Eva Pokorna Institute for Clinical and Experimental Medicine, Prague Czech Republic. Renal transplant biopsy is the gold standard for evaluation of graft dysfunction, establishment

524 views • 39 slides

Maastricht Classification of DCD

1.29k views • 30 slides

How far can we go with suboptimal grafts in LDLT.

416 views • 28 slides

Engaging ICU Teams

Engaging ICU Teams. Randy Janczyk, MD, FACS William Beaumont Hospital Royal Oak, Michigan. Case 1.

332 views • 20 slides

Using Belatacept

Using Belatacept. Allan D. Kirk, MD, PhD, FACS Professor of Surgery and Pediatrics Scientific Director, Emory Transplant Center Vice Chair for Research , Department of Surgery Emory University, Atlanta, Georgia. The Emory Transplant Center . What makes an immune response?.

616 views • 19 slides

Morning Report

Morning Report. February 17, 2010. Renal Transplants. Most frequent transplant 45% of all pediatric transplants 7% of renal transplants ? 17y 3 year survival exceeds survival on dialysis Age 0-14 Life expectancy increased by 30 years Age 15-19 Life expectancy increased by 25 years.

291 views • 17 slides

Age Group 00-14 years Graft Survival > 1 Year Function 1963-82, 1983-99, 1990-99

Age Group 00-14 years Graft Survival > 1 Year Function 1963-82, 1983-99, 1990-99. Australia. Years. Paed 50. Age Group 15-19 years Graft Survival > 1 Year Function 1963-82, 1983-99, 1990-99. Australia. Years. Paed 51. Age Group 00-14 years Graft Survival > 1 Year Function

307 views • 15 slides

SHOULD WE TRANSPLANT KIDNEYS FROM VERY OLD DONORS?

SHOULD WE TRANSPLANT KIDNEYS FROM VERY OLD DONORS?. Elijah Ablorsu M. Laftsidis; L Szabo Cardiff Transplant Unit, UK. UK Donor Activities. 33%. ESOT 2013 - Vienna. Should We ?. ESOT 2013 - Vienna. Should We ?. ESOT 2013 - Vienna. Single centre study Prospectively collected data

226 views • 13 slides

Topical and Subconjunctival Bevacizumab in Corneal Neovascularization in Keratoplasty Patients

556 views • 11 slides

The S. Fyodorov EYE MICROSURGERY STATE INSTITUTION, Moscow, Russia,

The S. Fyodorov EYE MICROSURGERY STATE INSTITUTION, Moscow, Russia,. Moscow. Ekaterinburg. S-Petersburg. Tambov. Novosibirsk. Kaluga. Cheboksary. Orenburg. Irkutsk. Khabarovsk. Volgograd. Krasnodar. ASCRS/ ASOA SYMPOSIUM ON CATARACT, IOL AND REFRACTIVE SURGERY

393 views • 11 slides

ABSTRACT

254 views • 1 slides